This study aimed to establish the effect of severe varus deformity on soft tissue balance in total knee arthroplasty (TKA), which is not yet well established. We retrospectively enrolled 205 patients (270 knees) who underwent primary TKA using the measured resection technique. Four intraoperatively measured TKA gaps and gap differences were compared between the severe varus deformity group (Hip-knee-ankle [HKA] varus angle ≥ 10°) and the mild varus deformity group (HKA varus angle < 10°). Pearson’s correlation analysis and multiple linear regression analysis were used to investigate the factors affecting flexion and extension gap differences (FGD and EGD). A receiver operating characteristic curve was applied to assess the cut-off value of the HKA varus angle to discriminate the rectangular gap. The FGD (1.42 ± 1.35 mm vs. 1.05 ± 1.16 mm, p = 0.019) and the EGD (1.45 ± 1.32 mm vs. 0.97 ± 1.53 mm, p = 0.006) were significantly larger in severe varus deformity group than in mild varus deformity group. The HKA varus angle was positively correlated with both FGD (r = 0.264, p < 0.001) and EGD (r = 0.319, p < 0.001) and was an influencing factor for FGD (β = 0.232, p = 0.040) and EGD (β = 0.229, p = 0.037). A preoperative HKA angle of 12.4° was selected as the cutoff value to discriminate between rectangular and trapezoidal gaps. Thus, the severity of varus deformity (HKA varus angle) was found to be a significant factor affecting the mediolateral gap difference in TKA. When performing TKA in a knee with an HKA varus angle ≥ 12.4°, a trapezoidal gap is more likely to be expected. Level of evidence III, case–control study.
Periprosthetic joint infection is among the most serious complications of joint replacement, and the implant surface, where infection begins, is a rational prevention target. Antibacterial titanium surfaces act by releasing an agent, by contact killing, or by resisting adhesion. Yet the field cannot readily tell which method performs best, because efficacy is evaluated with methods that differ at every level and are rarely comparable: the same surface can read as highly effective under one assay and inactive under another, so the test rather than the material decides the verdict. This review asks where comparability is lost and what would restore it, for permanent load-bearing arthroplasty implants. We dissect the gap across in vitro assays, durability testing, surface characterization, in vivo models, clinical infection definitions, and regulatory expectations and ask whether the antibacterial–osseointegration trade-off is assessed coherently. We then propose a ten-item, stage-stratified minimum-reporting checklist and test it retrospectively on thirteen open-access studies. No study reported every item required at its stage; none related antibacterial dose to a stated cytotoxicity threshold; and studies fell short at different tiers, so their reported efficacies are not commensurable. The checklist is offered as a testable starting point for multi-stakeholder consensus, not a finished standard.